Jalava T, Lehtovaara P, Kallio A, Ranki M, Söderlund H
Orion Corporation, Orion Pharmaceutica, Espoo, Finland.
Biotechniques. 1993 Jul;15(1):134-9.
Present methods for quantification of hepatitis B virus (HBV) particles from serum samples are not sensitive enough for some recent clinical applications. We describe a test that allows quantification of HBV DNA in a broad dynamic range from less than 40 to 10(6) molecules based on competitive PCR. The specimen DNA and a known amount of an internal standard (IS) are co-amplified in the same tube with the same primers, one of which is biotinylated. The two biotinylated products can be quantified by hybridization on microplates coated with streptavidin, because their internal sequences are nonhomologous. An adequate standard curve is obtained by amplifying HBV DNA from a plasmid clone together with an IS. The ratio of amplified HBV DNA to IS DNA enables quantification of the original amount of HBV without tedious titrations of each sample with competitor. The lower limit for quantitative analysis with radioactive probes was between 4 and 40 virus particles in a 10-microliters serum samples.
目前用于定量血清样本中乙肝病毒(HBV)颗粒的方法对于一些最新的临床应用来说灵敏度不够。我们描述了一种基于竞争性PCR的检测方法,该方法能够在从少于40到10⁶个分子的广泛动态范围内对HBV DNA进行定量。样本DNA和已知量的内标(IS)在同一管中用相同引物进行共扩增,其中一个引物是生物素化的。这两种生物素化产物可以通过在包被有链霉亲和素的微孔板上杂交来定量,因为它们的内部序列是不同源的。通过将来自质粒克隆的HBV DNA与一个IS一起扩增可获得一条合适的标准曲线。扩增的HBV DNA与IS DNA的比率能够对原始HBV量进行定量,而无需用竞争者对每个样本进行繁琐的滴定。使用放射性探针进行定量分析的下限在10微升血清样本中为4到40个病毒颗粒之间。